BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mealey KL. Canine ABCB1 and macrocyclic lactones: Heartworm prevention and pharmacogenetics. Veterinary Parasitology 2008;158:215-22. [DOI: 10.1016/j.vetpar.2008.09.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Drag M, Tielemans E, Mitchell E. Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1-deficient collie dogs. J Vet Pharmacol Ther 2022. [PMID: 35536118 DOI: 10.1111/jvp.13064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wells C, Collins CMT. A rapid evidence assessment of the potential risk to the environment presented by active ingredients in the UK’s most commonly sold companion animal parasiticides. Environ Sci Pollut Res. [DOI: 10.1007/s11356-022-20204-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ridgway M. Herding Dogs. Vet Clin North Am Small Anim Pract 2021;51:975-84. [PMID: 34059268 DOI: 10.1016/j.cvsm.2021.04.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Bates N. Poisons affecting the neurological system. The Veterinary Nurse 2020;11:116-25. [DOI: 10.12968/vetn.2020.11.3.116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Bates N. Poisons affecting the neurological system. Companion Animal 2020;25:83-91. [DOI: 10.12968/coan.2019.0072] [Reference Citation Analysis]
6 Silvestro CA, Soria LA, Conte A, Marrube G. Two methods for genotyping a 4-base deletion in the canine ABCB1 gene. J Vet Diagn Invest 2019;31:889-92. [PMID: 31711409 DOI: 10.1177/1040638719887374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Virkel G, Ballent M, Lanusse C, Lifschitz A. Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications. CMC 2019;26:1251-69. [DOI: 10.2174/0929867325666180201094730] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
8 Mealey KL, Martinez SE, Villarino NF, Court MH. Personalized medicine: going to the dogs? Hum Genet 2019;138:467-81. [PMID: 31032534 DOI: 10.1007/s00439-019-02020-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
9 Lahmers SM. Cardiovascular Pharmacotherapeutics. Pharmacotherapeutics for Veterinary Dispensing 2019. [DOI: 10.1002/9781119404576.ch10] [Reference Citation Analysis]
10 Merola VM, Eubig PA. Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats. Vet Clin North Am Small Anim Pract 2018;48:991-1012. [PMID: 30139545 DOI: 10.1016/j.cvsm.2018.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
11 Morgan E, O'connell K, Thomson M, Griffin A. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs. Vet Comp Oncol 2018;16:622-9. [DOI: 10.1111/vco.12430] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
12 Cochrane ZN, Berger DJ, Viall AK, Schrunk D, Hans Coetzee JF. Evaluation of compounded aqueous milbemycin oxime: issues with formulation potency and reproducibility. J Small Anim Pract 2019;60:27-31. [PMID: 29998573 DOI: 10.1111/jsap.12907] [Reference Citation Analysis]
13 Merino-Tejedor A, Nejsum P, Mkupasi EM, Johansen MV, Olsen A. Molecular identification of zoonotic hookworm species in dog faeces from Tanzania. J Helminthol 2019;93:313-8. [PMID: 29606160 DOI: 10.1017/S0022149X18000263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Morita T, Momota Y, Mori A, Oda H, Ike K, Sako T. Successful treatment of refractory demodicosis and transient papules with a single dose of fluralaner in a dog with uncontrolled severe endocrine disease. J Vet Med Sci 2018;80:672-5. [PMID: 29515061 DOI: 10.1292/jvms.17-0274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 . Ectrodactyly in Limousin calves. Vet Rec 2017;181:37-41. [PMID: 28694368 DOI: 10.1136/vr.j3126] [Reference Citation Analysis]
16 Lawrence J, Cameron D, Argyle D. Species differences in tumour responses to cancer chemotherapy. Philos Trans R Soc Lond B Biol Sci 2015;370:20140233. [PMID: 26056373 DOI: 10.1098/rstb.2014.0233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
17 Deshpande D, Hill KE, Mealey KL, Chambers JP, Gieseg MA. The Effect of the Canine ABCB1-1Δ Mutation on Sedation after Intravenous Administration of Acepromazine. J Vet Intern Med 2016;30:636-41. [PMID: 26822006 DOI: 10.1111/jvim.13827] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
18 Döring B, Petzinger E. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism. Drug Metab Rev 2014;46:261-82. [PMID: 24483608 DOI: 10.3109/03602532.2014.882353] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 8.5] [Reference Citation Analysis]
19 Bates N, Chatterton J, Robbins C, Wells K, Hughes J, Stone M, Campbell A. Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet rec case rep 2013;1. [DOI: 10.1136/vetreccr.101036rep] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Homeida MM, Malcolm SB, ElTayeb AZ, Eversole RR, Elassad AS, Geary TG, Ali MM, Mackenzie CD. The lack of influence of food and local alcoholic brew on the blood level of Mectizan(®) (ivermectin). Acta Trop 2013;127:97-100. [PMID: 23583861 DOI: 10.1016/j.actatropica.2013.03.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Martinez MN, Antonovic L, Court M, Dacasto M, Fink-gremmels J, Kukanich B, Locuson C, Mealey K, Myers MJ, Trepanier L. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics. Drug Metabolism Reviews 2013;45:218-30. [DOI: 10.3109/03602532.2013.765445] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
22 Bates N, Chatterton J, Robbins C, Wells K, Hughes J, Stone M, Campbell A. Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet Rec 2013;172:339. [PMID: 23423482 DOI: 10.1136/vr.101036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
23 Lappin MR. Anthelmintic Agents. Canine and Feline Gastroenterology 2013. [DOI: 10.1016/b978-1-4160-3661-6.00037-7] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Geyer J, Janko C. Treatment of MDR1 mutant dogs with macrocyclic lactones. Curr Pharm Biotechnol 2012;13:969-86. [PMID: 22039792 DOI: 10.2174/138920112800399301] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
25 Horspool LJI. Animal Health Markets and Opportunities: Companion Animal Landscape. In: Rathbone MJ, Mcdowell A, editors. Long Acting Animal Health Drug Products. New York: Springer US; 2013. pp. 15-46. [DOI: 10.1007/978-1-4614-4439-8_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Parton K, Wiffen E, Haglund N, Cave N. Macrocyclic lactone toxicity due to abamectin in farm dogs without the ABCB1 gene mutation. New Zealand Veterinary Journal 2012;60:194-7. [DOI: 10.1080/00480169.2011.642770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Merola VM, Eubig PA. Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats. Vet Clin North Am Small Anim Pract 2012;42:313-33, vii. [PMID: 22381182 DOI: 10.1016/j.cvsm.2011.12.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
28 Mizukami K, Chang H, Yabuki A, Kawamichi T, Hossain MA, Rahman MM, Uddin MM, Yamato O. Rapid genotyping assays for the 4–base pair deletion of canine MDR1 / ABCB1 gene and low frequency of the mutant allele in Border Collie dogs. J VET Diagn Invest 2012;24:127-34. [DOI: 10.1177/1040638711425591] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
29 Sherman JG. Understanding the impact of P-glycoprotein mutation on canine health. The Veterinary Journal 2011;190:13-14. [DOI: 10.1016/j.tvjl.2010.10.004] [Reference Citation Analysis]
30 Gramer I, Leidolf R, Döring B, Klintzsch S, Krämer E, Yalcin E, Petzinger E, Geyer J. Breed distribution of the nt230(del4) MDR1 mutation in dogs. The Veterinary Journal 2011;189:67-71. [DOI: 10.1016/j.tvjl.2010.06.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
31 Han JI, Son HW, Park SC, Na KJ. Novel insertion mutation of ABCB1 gene in an ivermectin-sensitive Border Collie. J Vet Sci 2010;11:341-4. [PMID: 21113104 DOI: 10.4142/jvs.2010.11.4.341] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
32 Brayden DJ, Oudot EJM, Baird AW. Drug Delivery Systems in Domestic Animal Species. In: Cunningham F, Elliott J, Lees P, editors. Comparative and Veterinary Pharmacology. Berlin: Springer Berlin Heidelberg; 2010. pp. 79-112. [DOI: 10.1007/978-3-642-10324-7_4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
33 Zhang W, Yang S, He H, Liu C, Chen W, Tang X. Technology for improving the bioavailability of small molecules extracted from traditional Chinese medicines. Expert Opin Drug Deliv 2009;6:1247-59. [PMID: 19852681 DOI: 10.1517/17425240903206963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Perez M, Blazquez AG, Real R, Mendoza G, Prieto JG, Merino G, Alvarez AI. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2. Chem Biol Interact. 2009;180:106-112. [PMID: 19428349 DOI: 10.1016/j.cbi.2009.02.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]